YND-28414-54652
4 vaccinations
7 coded responses
41 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 328 / FL
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion — Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness, NauseaFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Numbness in injected armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-02
- 2021-10-01
-
2021-11-18
Dose 3 — Pfizer-BioNTech
- 2021-11-18
- 2021-11-19
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-18
- 2021-12-23
-
2021-12-30
Survey response — day 42, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: PoorFree text: Sore throat; runny nose and congestion; cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-17
- 2022-05-19
-
2022-07-28
Dose 4 — Pfizer-BioNTech
-
2022-11-18
Survey response — 12 months, dose 3MedDRA: Hand-foot-and-mouth disease — Feeling: FairFree text: HFMD (Hand/Foot/Mouth)MedDRA releases: 2024-11 · check-in free text available
-
2023-01-28
Survey response — 6 months, dose 4MedDRA: COVID-19, Cough, Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-28
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-30
-
2023-02-02
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
| 4 | 2022-07-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-28 | Successful 2023-02-02 |
Completed over the phone |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Nasal congestion
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Numbness in injected arm
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose
Release 10 — day 42, dose 3
Symptoms: Sore throat; runny nose and congestion; cough.
Release 12 — 12 months, dose 3
Symptoms: HFMD (Hand/Foot/Mouth)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release